NCT00439634 Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia Status TERMINATED Phase PHASE2
NCT00435370 Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia Status COMPLETED Phase PHASE3
NCT00434980 Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia Status COMPLETED Phase NA
NCT00431223 Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training Status COMPLETED Phase NA
NCT00430560 Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia Status COMPLETED Phase PHASE2/PHASE3
NCT00430391 Comparison of Video Consent Versus Routine Consent for Participation in Research Studies Status COMPLETED Phase NA
NCT00428350 Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic Status COMPLETED Phase PHASE4
NCT00425815 Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia Status WITHDRAWN Phase PHASE2
NCT00423943 Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia Status COMPLETED Phase PHASE4
NCT00423878 Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE4
NCT00423033 Qualitative Analysis on the Experiences of Employment Among Schizophrenic Patients Status COMPLETED Phase N/A
NCT00420498 Effects of Atomoxetine on Cognitive Function in Schizophrenia Status COMPLETED Phase PHASE2
NCT00419653 Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy Status TERMINATED Phase PHASE4
NCT00419146 Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants Status COMPLETED Phase PHASE2/PHASE3